Macquarie Group LTD Uro Gen Pharma Ltd. Transaction History

Macquarie Group LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.12 - $8.74 $4,910 - $8,381	-959 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$17.99 - $26.96 $2,932 - $4,394	-163 Reduced 14.53%	959 $19,000
Q2 2020 Aug 11, 2020	BUY	$16.5 - $29.7 $18,513 - $33,323	1,122 New	1,122 $29,000
Q1 2018 May 11, 2018	SELL	$38.64 - $57.54 $11,592 - $17,262	-300 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$27.28 - $43.26 $8,184 - $12,978	300	300 $11,000

130

35.9M

22K

93.8K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $239M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.